EP3386514A4 - Vaginal inserted estradiol pharmaceutical compositions and methods - Google Patents
Vaginal inserted estradiol pharmaceutical compositions and methods Download PDFInfo
- Publication number
- EP3386514A4 EP3386514A4 EP16873806.0A EP16873806A EP3386514A4 EP 3386514 A4 EP3386514 A4 EP 3386514A4 EP 16873806 A EP16873806 A EP 16873806A EP 3386514 A4 EP3386514 A4 EP 3386514A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- methods
- pharmaceutical compositions
- vaginal
- estradiol pharmaceutical
- vaginal inserted
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
- A61K9/025—Suppositories; Bougies; Bases therefor; Ovules characterised by shape or structure, e.g. hollow layered, coated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4816—Wall or shell material
- A61K9/4825—Proteins, e.g. gelatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Reproductive Health (AREA)
- Gynecology & Obstetrics (AREA)
- Urology & Nephrology (AREA)
- Endocrinology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Diabetes (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Dermatology (AREA)
- Hematology (AREA)
- Pain & Pain Management (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201562264309P | 2015-12-07 | 2015-12-07 | |
US201662296552P | 2016-02-17 | 2016-02-17 | |
US201662324838P | 2016-04-19 | 2016-04-19 | |
US201662329940P | 2016-04-29 | 2016-04-29 | |
US201662348820P | 2016-06-10 | 2016-06-10 | |
PCT/US2016/065466 WO2017100378A2 (en) | 2015-12-07 | 2016-12-07 | Vaginal inserted estradiol pharmaceutical compositions and methods |
Publications (2)
Publication Number | Publication Date |
---|---|
EP3386514A2 EP3386514A2 (en) | 2018-10-17 |
EP3386514A4 true EP3386514A4 (en) | 2019-07-24 |
Family
ID=59014200
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP16873806.0A Withdrawn EP3386514A4 (en) | 2015-12-07 | 2016-12-07 | Vaginal inserted estradiol pharmaceutical compositions and methods |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP3386514A4 (en) |
JP (2) | JP2018538290A (en) |
KR (1) | KR20180100567A (en) |
AU (1) | AU2016366200B2 (en) |
BR (1) | BR112018011483A2 (en) |
CA (1) | CA3007636A1 (en) |
IL (1) | IL259884A (en) |
MX (1) | MX2018006882A (en) |
WO (1) | WO2017100378A2 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA3159370A1 (en) * | 2019-10-31 | 2021-05-06 | R.P. Scherer Technologies, Llc | Suppository capsule |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20140213565A1 (en) * | 2012-12-21 | 2014-07-31 | Therapeuticsmd, Inc. | Soluble estradiol capsule for vaginal insertion |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2739558B1 (en) * | 1995-10-05 | 1997-11-28 | Innothera Lab Sa | UNITAL GALENIC FORM FOR LOCAL HORMONOTHERAPY OF VAGINAL DROUGHT |
US6117446A (en) * | 1999-01-26 | 2000-09-12 | Place; Virgil A. | Drug dosage unit for buccal administration of steroidal active agents |
CN106038572A (en) * | 2004-10-20 | 2016-10-26 | 恩多研究公司 | Sex steroid precursors alone or in combination with a selective estrogen receptor modulator and/or with estrogens and/or a type 5 CGMP phosphodiesterase inhibitor for the prevention and treatment of vaginal dryness and sexual dysfunction in postmenopausal women |
EP2861073B1 (en) * | 2012-06-18 | 2021-04-14 | TherapeuticsMD, Inc. | Soluble estradiol capsule for vaginal insertion |
US10806697B2 (en) * | 2012-12-21 | 2020-10-20 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
-
2016
- 2016-12-07 BR BR112018011483A patent/BR112018011483A2/en not_active Application Discontinuation
- 2016-12-07 CA CA3007636A patent/CA3007636A1/en active Pending
- 2016-12-07 AU AU2016366200A patent/AU2016366200B2/en active Active
- 2016-12-07 JP JP2018529574A patent/JP2018538290A/en active Pending
- 2016-12-07 EP EP16873806.0A patent/EP3386514A4/en not_active Withdrawn
- 2016-12-07 WO PCT/US2016/065466 patent/WO2017100378A2/en active Application Filing
- 2016-12-07 MX MX2018006882A patent/MX2018006882A/en unknown
- 2016-12-07 KR KR1020187019331A patent/KR20180100567A/en unknown
-
2018
- 2018-06-07 IL IL259884A patent/IL259884A/en unknown
-
2021
- 2021-04-19 JP JP2021070619A patent/JP2021119155A/en active Pending
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20140213565A1 (en) * | 2012-12-21 | 2014-07-31 | Therapeuticsmd, Inc. | Soluble estradiol capsule for vaginal insertion |
Also Published As
Publication number | Publication date |
---|---|
AU2016366200A1 (en) | 2018-06-28 |
IL259884A (en) | 2018-07-31 |
BR112018011483A2 (en) | 2018-12-04 |
CA3007636A1 (en) | 2017-06-15 |
MX2018006882A (en) | 2019-05-16 |
KR20180100567A (en) | 2018-09-11 |
JP2021119155A (en) | 2021-08-12 |
EP3386514A2 (en) | 2018-10-17 |
AU2016366200B2 (en) | 2022-10-20 |
JP2018538290A (en) | 2018-12-27 |
WO2017100378A2 (en) | 2017-06-15 |
WO2017100378A3 (en) | 2018-02-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP3523437A4 (en) | Oligonucleotide compositions and methods thereof | |
EP3664815A4 (en) | Oligonucleotide compositions and methods thereof | |
EP3452596A4 (en) | Oligonucleotide compositions and methods thereof | |
EP3694530A4 (en) | Oligonucleotide compositions and methods thereof | |
EP3324978A4 (en) | Oligonucleotide compositions and methods thereof | |
EP3355954A4 (en) | Delivery methods and compositions | |
EP3630145A4 (en) | Pharmaceutical compositions comprising cannabidiol and beta-caryophyllene and methods for their use | |
EP3357513A4 (en) | Pharmaceutical composition and application thereof | |
EP3434285A4 (en) | Pharmaceutical composition and use thereof | |
EP3307265A4 (en) | Pharmaceutical combination and uses thereof | |
EP3347025A4 (en) | Methods and compositions for cancer treatment | |
EP3177286A4 (en) | Compositions and methods for physiological delivery using cannabidiol | |
EP3185873A4 (en) | Pharmaceutical composition and methods | |
EP3342419A4 (en) | Acne-removing traditional chinese medicine composition and preparation method thereof | |
EP3216450A4 (en) | Pharmaceutical preparation comprising cyclin inhibitor and preparation method thereof | |
EP3165219A4 (en) | Allisartan isoproxil solid dispersion and pharmaceutical composition comprising same | |
ZA201607148B (en) | Pharmaceutical composition including anti-fungal agent and steroid | |
EP3512529A4 (en) | Drug delivery compositions and methods | |
EP3344238A4 (en) | Laxative formulations and manufacture | |
HK1245113A1 (en) | Pharmaceutical compositions and use thereof | |
EP3328383A4 (en) | Antitussive compositions and methods | |
EP3349748A4 (en) | Composition and methods thereof | |
EP3307275A4 (en) | Injectable antibiotic formulations and use thereof | |
EP3615005A4 (en) | Compositions and methods for vaccine delivery | |
EP3373907A4 (en) | Sustained release pharmaceutical compositions and methods of use |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE |
|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
17P | Request for examination filed |
Effective date: 20180614 |
|
AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
AX | Request for extension of the european patent |
Extension state: BA ME |
|
DAV | Request for validation of the european patent (deleted) | ||
DAX | Request for extension of the european patent (deleted) | ||
A4 | Supplementary search report drawn up and despatched |
Effective date: 20190621 |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: A61P 15/02 20060101ALI20190614BHEP Ipc: A61K 31/565 20060101AFI20190614BHEP Ipc: A61K 9/48 20060101ALI20190614BHEP Ipc: A61K 9/00 20060101ALI20190614BHEP |
|
REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 1262604 Country of ref document: HK |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: EXAMINATION IS IN PROGRESS |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: EXAMINATION IS IN PROGRESS |
|
17Q | First examination report despatched |
Effective date: 20201216 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: EXAMINATION IS IN PROGRESS |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20230301 |